HRC 201
Alternative Names: HRC-201Latest Information Update: 16 Sep 2019
At a glance
- Originator Hemosol Corp
- Developer Therapure Biopharma
- Class Haemoglobins; Radiopharmaceutical diagnostics
- Mechanism of Action Magnetic resonance imaging enhancers; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Liver metastases
Most Recent Events
- 02 Feb 2004 HCR 201 is available for licensing (http://www.hrc.hemosol.com)
- 02 Feb 2004 Preclinical trials in Liver metastases (diagnosis) in Canada (unspecified route)